{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:16:05Z","timestamp":1791483365836,"version":"4.3.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/nrendo.2009.196","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T08:24:44Z","timestamp":1256113484000},"page":"611-619","source":"Crossref","is-referenced-by-count":382,"title":["The FGF23\u2013Klotho axis: endocrine regulation of phosphate homeostasis"],"prefix":"10.1038","volume":"5","author":[{"given":"M. Shawkat","family":"Razzaque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrendo2009196_CR1","first-page":"1","volume":"3","author":"A Rastegar","year":"2009","unstructured":"Rastegar, A. New concepts in pathogenesis of renal hypophosphatemic syndromes. Iran J. Kidney Dis. 3, 1\u20136 (2009).","journal-title":"Iran J. Kidney Dis."},{"key":"BFnrendo2009196_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","volume":"118","author":"A Gaasbeek","year":"2005","unstructured":"Gaasbeek, A. & Meinders, A. E. Hypophosphatemia: an update on its etiology and treatment. Am. J. Med. 118, 1094\u20131101 (2005).","journal-title":"Am. J. Med."},{"key":"BFnrendo2009196_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","volume":"69","author":"T Berndt","year":"2007","unstructured":"Berndt, T. & Kumar, R. Phosphatonins and the regulation of phosphate homeostasis. Annu. Rev. Physiol. 69, 341\u2013359 (2007).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrendo2009196_CR4","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1681\/ASN.2005050573","volume":"16","author":"EA Imel","year":"2005","unstructured":"Imel, E. A. & Econs, M. J. Fibroblast growth factor 23: roles in health and disease. J. Am. Soc. Nephrol. 16, 2565\u20132575 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR5","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles, L. D. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 118, 3820\u20133828 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/154411130401500503","volume":"15","author":"PS Rowe","year":"2004","unstructured":"Rowe, P. S. The wrickkened pathways of FGF23, MEPE and PHEX. Crit. Rev. Oral Biol. Med. 15, 264\u2013281 (2004).","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"BFnrendo2009196_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-012098652-1\/50122-0","volume-title":"Principles in Bone Biology","author":"M Drezner","year":"2002","unstructured":"Drezner, M. in Principles in Bone Biology (eds Bilezikian, J., Raisz, L. & Rodan, G.) 321\u2013338 (Academic Press, New York, 2002)."},{"key":"BFnrendo2009196_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000107069","volume":"27","author":"K Miyamoto","year":"2007","unstructured":"Miyamoto, K., Ito, M., Tatsumi, S., Kuwahata, M. & Segawa, H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am. J. Nephrol 27, 503\u2013515 (2007).","journal-title":"Am. J. Nephrol"},{"key":"BFnrendo2009196_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s007950200009","volume":"35","author":"MS Razzaque","year":"2002","unstructured":"Razzaque, M. S. & Taguchi, T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med. Electron Microsc. 35, 68\u201380 (2002).","journal-title":"Med. Electron Microsc."},{"key":"BFnrendo2009196_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.arr.2007.06.001","volume":"6","author":"MS Razzaque","year":"2007","unstructured":"Razzaque, M. S. Does renal ageing affect survival? Ageing Res. Rev. 6, 211\u2013222 (2007).","journal-title":"Ageing Res. Rev."},{"key":"BFnrendo2009196_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmed.2006.12.001","volume":"13","author":"T Taguchi","year":"2007","unstructured":"Taguchi, T. & Razzaque, M. S. The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol. Med. 13, 45\u201353 (2007).","journal-title":"Trends Mol. Med."},{"key":"BFnrendo2009196_CR12","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1073\/pnas.0704446104","volume":"104","author":"T Berndt","year":"2007","unstructured":"Berndt, T. et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc. Natl Acad. Sci. USA 104, 11085\u201311090 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2009196_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1152\/physrev.2000.80.4.1373","volume":"80","author":"H Murer","year":"2000","unstructured":"Murer, H., Hernando, N., Forster, I. & Biber, J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol. Rev. 80, 1373\u20131409 (2000).","journal-title":"Physiol. Rev."},{"key":"BFnrendo2009196_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ki.2008.33","volume":"73","author":"S Faroqui","year":"2008","unstructured":"Faroqui, S., Levi, M., Soleimani, M. & Amlal, H. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int. 73, 1141\u20131150 (2008).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/sj.ki.5001813","volume":"70","author":"IC Forster","year":"2006","unstructured":"Forster, I. C., Hernando, N., Biber, J. & Murer, H. Proximal tubular handling of phosphate: A molecular perspective. Kidney Int. 70, 1548\u20131559 (2006).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000106484","volume":"27","author":"S Tanaka","year":"2007","unstructured":"Tanaka, S. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL\/RANK\/OPG system. Am. J. Nephrol. 27, 466\u2013478 (2007).","journal-title":"Am. J. Nephrol."},{"key":"BFnrendo2009196_CR17","doi-asserted-by":"publisher","first-page":"C429","DOI":"10.1152\/ajpcell.00331.2004","volume":"288","author":"P Capuano","year":"2005","unstructured":"Capuano, P. et al. Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am. J. Physiol. Cell Physiol. 288, C429\u2013C434 (2005).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrendo2009196_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000112824","volume":"28","author":"Y Nabeshima","year":"2008","unstructured":"Nabeshima, Y. & Imura, H. alpha-Klotho: a regulator that integrates calcium homeostasis. Am. J. Nephrol. 28, 455\u2013464 (2008).","journal-title":"Am. J. Nephrol."},{"key":"BFnrendo2009196_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ndt\/gfm702","volume":"23","author":"MS Razzaque","year":"2008","unstructured":"Razzaque, M. S. Klotho and Na+, K+-ATPase activity: solving the calcium metabolism dilemma? Nephrol. Dial. Transplant. 23, 459\u2013461 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrendo2009196_CR20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"Imura, A. et al. alpha-Klotho as a regulator of calcium homeostasis. Science 316, 1615\u20131618 (2007).","journal-title":"Science"},{"key":"BFnrendo2009196_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T Yamashita","year":"2000","unstructured":"Yamashita, T., Yoshioka, M. & Itoh, N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 277, 494\u2013498 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo2009196_CR22","doi-asserted-by":"crossref","unstructured":"ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345\u2013348 (2000).","DOI":"10.1038\/81664"},{"key":"BFnrendo2009196_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00424-007-0231-5","volume":"454","author":"TJ Berndt","year":"2007","unstructured":"Berndt, T. J. et al. Biological activity of FGF-23 fragments. Pflugers Arch. 454, 615\u2013623 (2007).","journal-title":"Pflugers Arch."},{"key":"BFnrendo2009196_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429\u2013435 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2009196_CR25","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov, I. Z. et al. The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117, 4003\u20134008 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik, T. et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 195, 125\u2013131 (2007).","journal-title":"J. Endocrinol."},{"key":"BFnrendo2009196_CR27","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1210\/en.2004-0233","volume":"145","author":"X Bai","year":"2004","unstructured":"Bai, X., Miao, D., Li, J., Goltzman, D. & Karaplis, A. C. Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145, 5269\u20135279 (2004).","journal-title":"Endocrinology"},{"key":"BFnrendo2009196_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561\u2013568 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR29","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson, T. et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145, 3087\u20133094 (2004).","journal-title":"Endocrinology"},{"key":"BFnrendo2009196_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/path.2409","volume":"216","author":"S DeLuca","year":"2008","unstructured":"DeLuca, S. et al. Amelioration of the premature aging-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J. Pathol. 216, 345\u2013355 (2008).","journal-title":"J. Pathol."},{"key":"BFnrendo2009196_CR31","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson, K. B. et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N. Engl. J. Med. 348, 1656\u20131663 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009196_CR32","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1172\/JCI28163","volume":"116","author":"C Hafner","year":"2006","unstructured":"Hafner, C. et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J. Clin. Invest. 116, 2201\u20132207 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ajmg.a.30599","volume":"134","author":"WH Hoffman","year":"2005","unstructured":"Hoffman, W. H., Jueppner, H. W., Deyoung, B. R., O'Dorisio, M. S. & Given, K. S. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am. J. Med. Genet. A 134, 233\u2013236 (2005).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrendo2009196_CR34","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada, T. et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl Acad. Sci. USA 98, 6500\u20136505 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2009196_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci, M. et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 112, 683\u2013692 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ajmg.a.31106","volume":"140","author":"EG Farrow","year":"2006","unstructured":"Farrow, E. G. et al. Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am. J. Med. Genet. A 140, 537\u2013539 (2006).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrendo2009196_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux, B. et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248\u20131250 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrendo2009196_CR38","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","volume":"295","author":"S Liu","year":"2008","unstructured":"Liu, S. et al. Pathogenic role of Fgf23 in Dmp1-null mice. Am. J. Physiol. Endocrinol. Metab. 295, E254\u2013E261 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo2009196_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pag\u00e8s","year":"2005","unstructured":"Benet-Pag\u00e8s, A., Orlik, P., Strom, T. M. & Lorenz-Depiereux, B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum. Mol. Genet. 14, 385\u2013390 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo2009196_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","volume":"83","author":"Y Frishberg","year":"2005","unstructured":"Frishberg, Y. et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J. Mol. Med. 83, 33\u201338 (2005).","journal-title":"J. Mol. Med."},{"key":"BFnrendo2009196_CR41","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2006-0305","volume":"91","author":"HJ Garringer","year":"2006","unstructured":"Garringer, H. J. et al. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J. Clin. Endocrinol. Metab. 91, 4037\u20134042 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009196_CR42","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1210\/en.2008-0877","volume":"150","author":"S Ichikawa","year":"2009","unstructured":"Ichikawa, S. et al. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 150, 2543\u20132550 (2009).","journal-title":"Endocrinology"},{"key":"BFnrendo2009196_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ndt\/gfn620","volume":"24","author":"MS Razzaque","year":"2009","unstructured":"Razzaque, M. S. Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol. Dial. Transplant 24, 4\u20137 (2009).","journal-title":"Nephrol. Dial. Transplant"},{"key":"BFnrendo2009196_CR44","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel, E. A. et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J. Clin. Endocrinol. Metab. 91, 2055\u20132061 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009196_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/01.mnh.0000172717.49476.80","volume":"14","author":"M Fukagawa","year":"2005","unstructured":"Fukagawa, M., Nii-Kono, T. & Kazama, J. J. Role of fibroblast growth factor 23 in health and in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 14, 325\u2013329 (2005).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrendo2009196_CR46","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","volume":"65","author":"Y Imanishi","year":"2004","unstructured":"Imanishi, Y. et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int. 65, 1943\u20131946 (2004).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari, S. L., Bonjour, J. P. & Rizzoli, R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J. Clin. Endocrinol. Metab. 90, 1519\u20131524 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009196_CR48","doi-asserted-by":"publisher","first-page":"c94","DOI":"10.1159\/000086347","volume":"101","author":"H Nishi","year":"2005","unstructured":"Nishi, H. et al. Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. Nephron Clin. Pract. 101, c94\u2013c99 (2005).","journal-title":"Nephron Clin. Pract."},{"key":"BFnrendo2009196_CR49","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito, H. et al. Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem. 280, 2543\u20132549 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2009196_CR50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu, S. et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17, 1305\u20131315 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","volume":"44","author":"T Shigematsu","year":"2004","unstructured":"Shigematsu, T. et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am. J. Kidney Dis. 44, 250\u2013256 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrendo2009196_CR52","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez, O. et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J. Am. Soc. Nephrol. 16, 2205\u20132215 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2215\/CJN.01520407","volume":"2","author":"AJ Felsenfeld","year":"2007","unstructured":"Felsenfeld, A. J., Rodr\u00edguez, M. & Aguilera-Tejero, E. Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism. Clin. J. Am. Soc. Nephrol. 2, 1283\u20131305 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR54","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","volume":"67","author":"S Nakanishi","year":"2005","unstructured":"Nakanishi, S. et al. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int. 67, 1171\u20131178 (2005).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR55","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata, T. et al. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J. Am. Soc. Nephrol. 18, 2683\u20132688 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR56","doi-asserted-by":"publisher","first-page":"p59","DOI":"10.1159\/000210389","volume":"111","author":"F Saji","year":"2009","unstructured":"Saji, F. et al. Regulation of fibroblast growth factor 23 production in bone in uremic rats. Nephron Physiol. 111, p59\u2013p66 (2009).","journal-title":"Nephron Physiol."},{"key":"BFnrendo2009196_CR57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez, O. M. et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 359, 584\u2013592 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009196_CR58","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser, D. et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J. Am. Soc. Nephrol. 18, 2600\u20132608 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","volume":"337","author":"HJ Hsu","year":"2009","unstructured":"Hsu, H. J. & Wu, M. S. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am. J. Med. Sci. 337, 116\u2013122 (2009).","journal-title":"Am. J. Med. Sci."},{"key":"BFnrendo2009196_CR60","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez, O. M. et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119, 2545\u20132552 (2009).","journal-title":"Circulation"},{"key":"BFnrendo2009196_CR61","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/01.CIR.0000124224.48962.32","volume":"109","author":"K Takeshita","year":"2004","unstructured":"Takeshita, K. et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109, 1776\u20131782 (2004).","journal-title":"Circulation"},{"key":"BFnrendo2009196_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45\u201351 (1997).","journal-title":"Nature"},{"key":"BFnrendo2009196_CR63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","volume":"242","author":"Y Matsumura","year":"1998","unstructured":"Matsumura, Y. et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 242, 626\u2013630 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo2009196_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(98)00127-6","volume":"424","author":"T Shiraki-Iida","year":"1998","unstructured":"Shiraki-Iida, T. et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 424, 6\u201310 (1998).","journal-title":"FEBS Lett."},{"key":"BFnrendo2009196_CR65","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1006\/bbrc.1998.9576","volume":"251","author":"Y Ohyama","year":"1998","unstructured":"Ohyama, Y. et al. Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. Biochem. Biophys. Res. Commun. 251, 920\u2013925 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo2009196_CR66","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","volume":"104","author":"CD Chen","year":"2007","unstructured":"Chen, C. D., Podvin, S., Gillespie, E., Leeman, S. E. & Abraham, C. R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc. Natl Acad. Sci. USA 104, 19796\u201319801 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2009196_CR67","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu, H. et al. Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120\u20136123 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2009196_CR68","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1096\/fj.08-114397","volume":"23","author":"T Nakatani","year":"2009","unstructured":"Nakatani, T. et al. In vivo genetic evidence of klotho-dependent functions of FGF23 in regulation of systemic phosphate homeostasis. FASEB J. 23, 433\u2013441 (2009).","journal-title":"FASEB J."},{"key":"BFnrendo2009196_CR69","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molmed.2006.05.002","volume":"12","author":"MS Razzaque","year":"2006","unstructured":"Razzaque, M. S. & Lanske, B. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298\u2013305 (2006).","journal-title":"Trends Mol. Med."},{"key":"BFnrendo2009196_CR70","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770\u2013774 (2006).","journal-title":"Nature"},{"key":"BFnrendo2009196_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.arr.2007.02.002","volume":"6","author":"B Lanske","year":"2007","unstructured":"Lanske, B. & Razzaque, M. S. Premature aging in klotho mutant mice: cause or consequence? Ageing Res. Rev. 6, 73\u201379 (2007).","journal-title":"Ageing Res. Rev."},{"key":"BFnrendo2009196_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139\u2013149 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrendo2009196_CR73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","volume":"16","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi, M., Olsen, S. K. & Ibrahimi, O. A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107\u2013137 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrendo2009196_CR74","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni, J. et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am. J. Physiol. Renal Physiol. 297, F282\u2013F291 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrendo2009196_CR75","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1681\/ASN.2007121301","volume":"19","author":"S Liu","year":"2008","unstructured":"Liu, S., Vierthaler, L., Tang, W., Zhou, J. & Quarles, L. D. FGFR3 and FGFR4 do not mediate renal effects of FGF23. J. Am. Soc. Nephrol. 19, 2342\u20132350 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR76","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki, Y. et al. Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J. Bone Miner. Res. 23, 1509\u20131518 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2009196_CR77","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.200803024","volume":"182","author":"D Medici","year":"2008","unstructured":"Medici, D. et al. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J. Cell Biol. 182, 459\u2013465 (2008).","journal-title":"J. Cell Biol."},{"key":"BFnrendo2009196_CR78","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1681\/ASN.2008070783","volume":"20","author":"EG Farrow","year":"2009","unstructured":"Farrow, E. G., Davis, S. I., Summers, L. J. & White, K. E. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J. Am. Soc. Nephrol. 20, 955\u2013960 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2009196_CR79","doi-asserted-by":"crossref","unstructured":"Nakatani, T., Ohnishi, M. & Razzaque, M. S. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. doi:10.1096\/fj.08-123992.","DOI":"10.1096\/fj.08-123992"},{"key":"BFnrendo2009196_CR80","doi-asserted-by":"publisher","first-page":"F470","DOI":"10.1152\/ajprenal.90538.2008","volume":"296","author":"MS Razzaque","year":"2009","unstructured":"Razzaque, M. S. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am. J. Physiol. Renal Physiol. 296, F470\u2013F476 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrendo2009196_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0095","volume":"194","author":"MS Razzaque","year":"2007","unstructured":"Razzaque, M. S. & Lanske, B. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J. Endocrinol. 194, 1\u201310 (2007).","journal-title":"J. Endocrinol."},{"key":"BFnrendo2009196_CR82","doi-asserted-by":"publisher","first-page":"E79","DOI":"10.1152\/ajpendo.90539.2008","volume":"296","author":"X Bai","year":"2009","unstructured":"Bai, X., Dinghong, Q., Miao, D., Goltzman, D. & Karaplis, A. C. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype. Am. J. Physiol. Endocrinol. Metab. 296, E79\u2013E88 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo2009196_CR83","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa, S. et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684\u20132691 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009196_CR84","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Miner. Res. 23, 939\u2013948 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2009196_CR85","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1210\/en.2005-0670","volume":"146","author":"X Yu","year":"2005","unstructured":"Yu, X. et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146, 4647\u20134656 (2005).","journal-title":"Endocrinology"},{"key":"BFnrendo2009196_CR86","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf, M. et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72, 1004\u20131013 (2007).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR87","doi-asserted-by":"crossref","unstructured":"Aono, Y. et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J. Bone Miner. Res. doi:10.1359\/jbmr.090509.","DOI":"10.1359\/jbmr.090509"},{"key":"BFnrendo2009196_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3177\/jnsv.55.99","volume":"55","author":"K Kusano","year":"2009","unstructured":"Kusano, K., Saito, H., Segawa, H., Fukushima, N. & Miyamoto, K. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 99\u2013105 (2009).","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"BFnrendo2009196_CR89","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1096\/fj.05-5432fje","volume":"20","author":"MS Razzaque","year":"2006","unstructured":"Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R. & Lanske, B. Premature ageing-like phenotype in fibroblast growth factor 23 null mice is a vitamin-D mediated process. FASEB J. 20, 720\u2013722 (2006).","journal-title":"FASEB J."},{"key":"BFnrendo2009196_CR90","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ki.2009.24","volume":"75","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi, M., Nakatani, T., Lanske, B. & Razzaque, M. S. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int. 75, 1166\u20131172 (2009).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR91","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2106\/JBJS.H.00783","volume":"91","author":"L Masi","year":"2009","unstructured":"Masi, L. et al. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J. Bone Joint Surg. Am. 91, 1190\u20131198 (2009).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFnrendo2009196_CR92","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000197876","volume":"71","author":"JJ Lammoglia","year":"2009","unstructured":"Lammoglia, J. J. & Mericq, V. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm. Res. 71, 178\u2013184 (2009).","journal-title":"Horm. Res."},{"key":"BFnrendo2009196_CR93","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","volume":"70","author":"I Bhan","year":"2006","unstructured":"Bhan, I. et al. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int. 70, 1486\u20131494 (2006).","journal-title":"Kidney Int."},{"key":"BFnrendo2009196_CR94","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00198-006-0154-6","volume":"17","author":"M Inaba","year":"2006","unstructured":"Inaba, M. et al. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos. Int. 17, 1506\u20131513 (2006).","journal-title":"Osteoporos. Int."},{"issue":"Suppl. 2","key":"BFnrendo2009196_CR95","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1177\/089686080702702s37","volume":"27","author":"T Stomp\u00f3r","year":"2007","unstructured":"Stomp\u00f3r, T. An overview of the pathophysiology of vascular calcification in chronic kidney disease. Perit. Dial. Int. 27 (Suppl. 2), S215\u2013S222 (2007).","journal-title":"Perit. Dial. Int."},{"key":"BFnrendo2009196_CR96","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1525-139X.2007.00332.x","volume":"20","author":"SS DeLoach","year":"2007","unstructured":"DeLoach, S. S. & Berns, J. S. Arterial stiffness and vascular calcification in dialysis patients: new measures of cardiovascular risk. Semin. Dial. 20, 477\u2013479 (2007).","journal-title":"Semin. Dial."},{"key":"BFnrendo2009196_CR97","first-page":"196","volume":"29","author":"A Negri","year":"2009","unstructured":"Negri, A. FGF23 in chronic kidney disease and kidney post-transplant patients [Spanish]. Nefrologia 29, 196\u2013202 (2009).","journal-title":"Nefrologia"},{"key":"BFnrendo2009196_CR98","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11255-008-9466-0","volume":"41","author":"S Ibrahim","year":"2009","unstructured":"Ibrahim, S. & Rashed, L. Serum fibroblast growth factor-23 levels in chronic haemodialysis patients. Int. Urol. Nephrol. 41, 163\u2013169 (2009).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrendo2009196_CR99","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/ncpendmet0667","volume":"3","author":"MS Razzaque","year":"2007","unstructured":"Razzaque, M. S. Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? Nat. Clin. Pract. Endocrinol. Metab. 3, 788\u2013789 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.196","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:32:17Z","timestamp":1684467137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":99,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFnrendo2009196"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.196","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}